Role of serum thyroglobulin as a surrogate marker in evaluating outcome following radioiodine therapy in differentiated thyroid cancer

被引：0
|
作者：
Pradhan, Prasanta [2 ]
Mammoottil, Alen [2 ]
Gambhir, Sanjay [2 ]
Mishra, Saroj [1 ]
Mishra, Anjali [1 ]
机构：
[1] SGPGIMS, Endosurg, Lucknow, Uttar Pradesh, India
[2] SGPGIMS, Nucl Med, Lucknow, Uttar Pradesh, India
来源：
JOURNAL OF NUCLEAR MEDICINE | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1537
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Serum thyroglobulin as a prognostic marker before radioiodine ablation in patients with differentiated thyroid cancer
    Takacsova, E.
    Kralik, R.
    Kausitz, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S542 - S542
  • [2] Thyroglobulin autoantibodies before radioiodine ablation predict differentiated thyroid cancer outcome
    Trimboli, Pierpaolo
    Zilioli, Valentina
    Imperiali, Mauro
    Giovanella, Luca
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2017, 55 (12) : 1995 - 2001
  • [3] Outcome of radioiodine therapy in risk stratified differentiated thyroid cancer
    Pradhan, Prasanta
    Mammoottil, Alen
    Gambhir, Sanjay
    Mishra, Saroj
    Mishra, Anjali
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [4] Approach to the patient with a positive serum thyroglobulin and a negative radioiodine scan after initial therapy for differentiated thyroid cancer
    Kloos, Richard T.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (05): : 1519 - 1525
  • [5] Efficacy of empirical radioiodine therapy in patients with differentiated thyroid cancer and elevated serum thyroglobulin without evidence of structural disease
    Piscopo, L.
    Zampella, E.
    Nappi, C.
    Volpe, F.
    Gaudieri, V.
    Bianco, D.
    Volpicelli, F.
    Falzarano, M.
    Pace, L.
    Cuocolo, A.
    Klain, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S670 - S670
  • [6] High therapeutic dosages of radioiodine in differentiated thyroid cancer patients with detectable serum thyroglobulin.
    de Keizer, B
    de Klerk, JM
    Koppeschaar, HP
    Zelissen, PM
    Lips, CM
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 308P - 308P
  • [7] Serum thyroglobulin measurements in differentiated thyroid cancer
    Girelli, ME
    De Vido, D
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2000, 54 (06) : 330 - 333
  • [8] Serum thyroglobulin in the monitoring of differentiated thyroid cancer
    Evans, Carol
    Tennant, Sarah
    Perros, Petros
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2016, 76 : S119 - S123
  • [9] SERUM THYROGLOBULIN IN DIFFERENTIATED THYROID-CANCER
    HAY, ID
    GORMAN, CA
    [J]. BRITISH MEDICAL JOURNAL, 1979, 2 (6197): : 1076 - 1076
  • [10] Variation of serum thyroglobulin during the first radioiodine therapy: a prognostic marker in patients with thyroid carcinoma?
    Lopo, I.
    Lapa, P.
    Costa, G.
    Pedroso de Lima, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S191 - S191
12345